These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Insulin sensitivity and the effects of antihypertensive agents: implications for the treatment of hypertension in the patient with diabetes mellitus. Simonson DC. Postgrad Med J; 1988; 64 Suppl 3():39-47; discussion 48-9. PubMed ID: 3074296 [Abstract] [Full Text] [Related]
23. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects]. Zukowska-Szczechowska E, Tomaszewski M, Grzeszczak W. Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857 [Abstract] [Full Text] [Related]
25. [Antihypertensive treatment in type II diabetes and diabetic nephropathy]. Chantrel F, Bouiller M, Kolb I, Hannedouche T. Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204 [Abstract] [Full Text] [Related]
29. [Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)]. Hanssen KF, Jenssen T. Tidsskr Nor Laegeforen; 1992 Mar 10; 112(7):912-4. PubMed ID: 1557762 [Abstract] [Full Text] [Related]
30. [Costs of antihyperglycemic treatment and consumables and treatment satisfaction in patients with type 2 diabetes]. Schröder J, Kerner W. Dtsch Med Wochenschr; 2009 Nov 10; 134(46):2355; author reply 2355-6. PubMed ID: 19894207 [No Abstract] [Full Text] [Related]
31. Hypertension in patients with diabetes: questions. Bloomgarden Z, Guang N. J Diabetes; 2010 Sep 10; 2(3):128-9. PubMed ID: 20923477 [No Abstract] [Full Text] [Related]
33. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications]. Wolffenbuttel BH, Heine RJ. Ned Tijdschr Geneeskd; 1999 Jun 05; 143(23):1197-201. PubMed ID: 10389533 [Abstract] [Full Text] [Related]
34. [Economics under scrutiny - experts discuss long acting insulin analogs]. Pflege Z; 2011 Jan 05; 64(1):58. PubMed ID: 21305792 [No Abstract] [Full Text] [Related]
38. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Brown JB, Nichols GA, Glauber HS, Bakst AW. Diabetes Care; 1999 Jul 05; 22(7):1116-24. PubMed ID: 10388977 [Abstract] [Full Text] [Related]
39. [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]. Hanaire H, Attali C, Lecointre B, Fraysse M, Gouet D, Babel MR, Charbonnel B, Sarkozy F, Gourmelen J, Detournay B. Sante Publique; 2016 Dec 19; 28(6):781-789. PubMed ID: 28155773 [Abstract] [Full Text] [Related]